Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
When a top executive sells nearly 5,000 shares of Alpha and Omega Semiconductor, investors pause. This article breaks...
President Trump pivots his inflation push toward gasoline retailers, aiming for pump relief as inflation remains abov...
Lenders and developers are embracing AI, yet the path to residential land remains blocked by entitlements, infrastruc...
Moody's Analytics estimates the typical U.S. household has shouldered roughly $2,000 in costs tied to Iran-related sp...
The United States is imposing 25% tariffs on imports from Brazil, with exemptions for key items like coffee and beef....
A top executive at Urban Outfitters sold a sizable block of stock in a short time frame. This article breaks down wha...
As 2026 unfolds, four online real estate schools rise to the top for licensing education, offering flexible formats, ...
A leading fiscal watchdog warns that the U.S. is entering a high-risk moment as debt nears 100% of GDP and calls for ...
Tesla sits near the $400 mark as investors weigh future growth against current prices. This guide helps you decide wh...
As March 27 nears, travel and markets face a critical test: TSA delays mount and a partial shutdown looms, threatenin...
Geopolitical risk in the Middle East adds new headwinds for Nvidia, threatening its Taiwan-based chip supply chain an...